Lawmakers consider limiting how long existing WuXi contracts can continue
House members want drugmakers to end their existing contracts with WuXi AppTec and other Chinese firms by 2032, two sources told Endpoints News.
The Biosecure Act, under its current Senate iteration, proposes to essentially ban popular Chinese contractors from inking new US deals. Now, newly drafted language would further crack down on these companies by sunsetting their contracts that are already in progress. A 2032 deadline, while still years away, would impact an industry that deals in long timelines.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.